37 related articles for article (PubMed ID: 38445914)
1. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
[TBL] [Abstract][Full Text] [Related]
2. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
[TBL] [Abstract][Full Text] [Related]
3. Associations of adipose and muscle tissue parameters at colorectal cancer diagnosis with long-term health-related quality of life.
van Roekel EH; Bours MJL; Te Molder MEM; Breedveld-Peters JJL; Olde Damink SWM; Schouten LJ; Sanduleanu S; Beets GL; Weijenberg MP
Qual Life Res; 2017 Jul; 26(7):1745-1759. PubMed ID: 28315175
[TBL] [Abstract][Full Text] [Related]
4. Re-Evaluating Chemotherapy Dosing Strategies for Ovarian Cancer: Impact of Sarcopenia.
Shah R; Polen-De C; McGree M; Fought A; Kumar A
Curr Oncol; 2023 Oct; 30(11):9501-9513. PubMed ID: 37999108
[TBL] [Abstract][Full Text] [Related]
5. Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.
Wood BS; Batchek DJ; Lynch DH; Spangler HB; Gross DC; Petersen CL; Batsis JA
Calcif Tissue Int; 2024 Jan; 114(1):60-73. PubMed ID: 37758867
[TBL] [Abstract][Full Text] [Related]
6. Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy.
Chaunzwa TL; Qian JM; Li Q; Ricciuti B; Nuernberg L; Johnson JW; Weiss J; Zhang Z; MacKay J; Kagiampakis I; Bikiel D; Di Federico A; Alessi JV; Mak RH; Jacob E; Awad MM; Aerts HJWL
JAMA Oncol; 2024 May; ():. PubMed ID: 38780929
[TBL] [Abstract][Full Text] [Related]
7. Association of body composition and survival in patients with locally advanced breast cancer: a historical cohort study.
Pakdee W; Laohawiriyakamol T; Tanutit P; Laohawiriyakamol S; Liabsuetrakul T
Acta Radiol; 2024 Jun; 65(6):575-587. PubMed ID: 38591936
[TBL] [Abstract][Full Text] [Related]
8. Association of low muscle mass index and sarcopenic obesity with knee osteoarthritis: a systematic review and meta-analysis.
Wu Q; Xu Z; Ma X; Li J; Du J; Ji J; Ling X; Kan J; Zhao M
J Int Soc Sports Nutr; 2024 Dec; 21(1):2352393. PubMed ID: 38775452
[TBL] [Abstract][Full Text] [Related]
9. [Research Progress in the Association Between Sarcopenic Obesity and Cancer].
Xu CL; Liu YW; Guo Q; Yu Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):267-274. PubMed ID: 38686725
[TBL] [Abstract][Full Text] [Related]
10. Bibliometric analysis of research on sarcopenic obesity: a review of scientific literature.
Petermann-Rocha F; Diaz-Toro F; Valera-Gran D; Navarrete-Muñoz EM
Obes Rev; 2024 May; ():e13784. PubMed ID: 38807369
[TBL] [Abstract][Full Text] [Related]
11. Unique compositional signature, pathophysiology and clinical implications of sarcopenic obesity.
Chen LK
Arch Gerontol Geriatr; 2024 May; ():105501. PubMed ID: 38821729
[No Abstract] [Full Text] [Related]
12. Sarcopenia and Coronary Microvascular Dysfunction: "Attention Must Be Paid".
Schindler TH; Peterson LR
JACC Cardiovasc Imaging; 2024 Feb; 17(2):192-194. PubMed ID: 37921723
[No Abstract] [Full Text] [Related]
13. [The role of the musculoadipose status in the assessment of the risk profile before liver transplantation].
Deeb AA; Rauchfuß F; Settmacher U
Chirurgie (Heidelb); 2024 Jun; ():. PubMed ID: 38829546
[TBL] [Abstract][Full Text] [Related]
14. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
[TBL] [Abstract][Full Text] [Related]
15. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
Sohal DPS; Duong M; Ahmad SA; Gandhi NS; Beg MS; Wang-Gillam A; Wade JL; Chiorean EG; Guthrie KA; Lowy AM; Philip PA; Hochster HS
JAMA Oncol; 2021 Mar; 7(3):421-427. PubMed ID: 33475684
[TBL] [Abstract][Full Text] [Related]
18. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
19. The association of body composition on chemotherapy toxicities in non-metastatic colorectal cancer patients: a systematic review.
Choi CS; Kin K; Cao K; Hutcheon E; Lee M; Chan STF; Arafat Y; Baird PN; Yeung JMC
ANZ J Surg; 2024 Mar; 94(3):327-334. PubMed ID: 38059530
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
